Novartis · 2 weeks ago
Senior Program Head
East Hanover, NJ
Full-time
Hybrid
Senior Level, Lead/Staff
$248K/yr - $462K/yr
8+ years expNovartis is a company dedicated to transforming healthcare and improving patient outcomes. They are seeking an Early Portfolio Global Program Head who will lead strategic initiatives, manage the program lifecycle, and foster stakeholder relationships to deliver innovative medicines. The role emphasizes collaboration, team development, and navigating complex healthcare landscapes.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Drive the program's transformational vision, devise an adaptable strategy that anticipates future trends and challenges, and translate strategies into practical, impactful plans
Seek out and combine complex internal/external elements to inform business decision-making, identify key issues in complex scenarios, and ensure clarity
Embody an enterprise leader that works across the entire Novartis research-development-commercial continuum to understand the impact of decisions, the benefit of diverse perspective, and the power of our shared purpose
Deliver organization-wide impact through an understanding and respect for an evolving technological landscape, including knowing when and how to incorporate new tools into existing strategies while evolving ahead of anticipated capabilities (e.g., precision medicine, AI, blockchain, nanotechnology)
The GPH has sole accountability of and responsibility to deliver enterprise value by defining the asset’s strategic vision, optimize life cycle management, and drive the integrated development plans to ensure successful regulatory and access outcomes
Leads the design of the Target Product Profile (TPP) and the Integrated Development Plan (IDP)
Accountable for end-to-end program leadership, including formally representing the program internally and externally, instigating innovation in early-stage development processes, issuing recommendations, making decisions to ensure the program success and asset value optimization, and ultimately propelling the program through preliminary testing and approval stages
Uphold regulatory compliance and meet initial stage commitments regarding prototype quality, timeline, projected cost, and potential value. Candidly communicate program impact projections and assess the early-stage commercial viability
Empower the team through clear roles/responsibilities, prioritizing individual growth, and holding team accountable for ambitious goals
Nurture a well-performing team that fosters collaboration and supportive challenge
Maintain positive relationships with stakeholders, ensuring clear, concise communication throughout the program lifecycle, and handle conflicts diplomatically
Build positive relationships with stakeholders; provide clear, concise communication about preliminary venture details and expertly navigate any arising conflicts
Enhance stakeholder understanding of program objectives/risks, influence their expectations through scientific and evidence-based communication, and involving stakeholders in decision-making processes. Adjust strategies based on stakeholders' needs, expectations, and potential responses
Foster stakeholders' understanding of project aims and inherent risks during initial development, shape their expectations through scientific evidence-based dialogue, and include them in decision-making processes. Adapt strategies by anticipating stakeholders concerns, needs, and possible responses
Qualification
Required
MD preferred or PhD with strong scientific background
Experience in Immunology is required
Min 8 years of drug development experience, including experience in dossier submission for new or supplemental indication
Exposure to full drug development lifecycle
Managing cross-functional teams and intense cross-functional collaboration and alignment
Leading teams through influence without direct authority
Communicating clearly and concisely with various audiences, adjusting messaging, style, tone, and details to best fit different audiences
Experience in forming and driving transformative visions and strategic plans for early-stage programs
Background in team management, developing roles, and fostering a high-performance culture
Previous interactions with early stage/scientific stakeholders, emphasizing clear communication and involvement in decision-making
Experience in anticipating and crafting adaptive, resilient strategies for early-stage innovation and scenario planning
Benefits
Sign-on bonus
Restricted stock units
Discretionary awards
Full range of medical
Financial
401(k) eligibility
Various paid time off benefits
Vacation
Sick time
Parental leave
Company
Novartis
Novartis is a pharmaceutical company that researches and develops medicines for serious diseases to improve and extend people's lives.
10001+ employees
H1B Sponsorship
Novartis has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (27)
2023 (23)
2022 (27)
2021 (31)
2020 (25)
Funding
Current Stage
Public CompanyTotal Funding
$2.49BKey Investors
Bill & Melinda Gates Foundation
2024-06-19Post Ipo Debt· $2.49B
2018-02-14Grant· $6.5M
2000-05-19IPO
Leadership Team
Daniel Grant
Vice President & Global Program Head
John von Brachel
VP, Head of Content Lab
Recent News
2026-01-11
Company data provided by crunchbase